Rayo Pharma Private Limited

Rayo Pharma Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN U33119GJ2018PTC104863 Incorporated 23 October 2018 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2024
₹29.35 Lakh
▼ 85% YoY
Net loss · FY 2024
₹52.98 Lakh
Net margin -180.5%
EBITDA · FY 2024
-₹51.95 Lakh
EBITDA margin -177%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Rayo Pharma Private Limited

Data last updated:

Rayo Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 October 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U33119GJ2018PTC104863. Its GSTIN is 24AAJCR2164A1ZT (Gujarat).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Ashik Dhirubhai Sanghvi and Jigneshkumar Arvindbhai Patel.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 12 Navjivan (Kalyan) Co Op H Soc Near Nagari Hospital Ellis Bridge, Ahmedabad, Gujarat, India – 380006.

As per the financials filed for FY 2024, the company reported a revenue of ₹29.35 Lakh, a decline of 85% compared to the previous year. For the same year it recorded a net loss of ₹52.98 Lakh (net margin -180.5%) and EBITDA of -₹51.95 Lakh (EBITDA margin -177%). Revenue has declined at a compounded annual rate (CAGR) of 34% over three years.

Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.

Rayo Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0006428). For more details, the company can be reached via its website rayopharma.in.

Company details

CIN U33119GJ2018PTC104863
Registration Number 104863
Incorporation Date 23 October 2018
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0006428
Key People
Ashik Dhirubhai Sanghvi Director Jigneshkumar Arvindbhai Patel Director Munir Mahendrakumar Shah Director

Recognitions & Rankings of Rayo Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-GJ-01-0006428

Contact details

Rayo Pharma Private Limited's registered office is in Ahmedabad, Gujarat. Its website is rayopharma.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    rayopharma.in
  • Registered Address
    12 Navjivan (Kalyan) Co Op H Soc Near Nagari Hospital Ellis Bridge, Ahmedabad, Gujarat, India – 380006
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Rayo Pharma Private Limited, buy the company report.

Comprehensive company report
Rayo Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Rayo Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Rayo Pharma Private Limited, buy the company report.

Financials of Rayo Pharma Private Limited

FY 2025 filings available

Rayo Pharma Private Limited reported revenue of ₹29.35 Lakh (down 85% YoY) for FY 2024.

Revenue · FY 2024
₹29.35 Lakh ▼ 85%
Net loss · FY 2024
₹52.98 Lakh margin -180.5%
EBITDA · FY 2024
-₹51.95 Lakh margin -177%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 85%
3 years · compounded
▼ 34%
EBITDA CAGR growth
1 year
▼ 162%
3 years · compounded
▲ 6%
5 years · compounded
▼ 99%

Revenue has declined at a compounded annual rate (CAGR) of 34% over three years, including a 85% fall in the latest year. EBITDA fell 162% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹51.95 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹52.98 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-177%
Net Profit Margin-180.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Rayo Pharma Private Limited, buy the company report.

Board of directors of Rayo Pharma Private Limited

Rayo Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ashik Dhirubhai Sanghvi
Also directs: R Kromme Developer LLP, BSG Reality LLP, Ratnaraj Reality LLP and 2 more
Director23 Oct 20188 Years 0 MonthsCurrent
Jigneshkumar Arvindbhai Patel
Also directs: BSG Reality LLP, Ratnaraj Reality LLP, Goodluck Infra Enterprise LLP and 1 more
Director23 Oct 20188 Years 0 MonthsCurrent
Munir Mahendrakumar Shah
Also directs: Aadi Agroprocess LLP, Samvatt Enterprise LLP, Aadi Infrabuild LLP and 5 more
Director23 Oct 20188 Years 0 MonthsCurrent
View all directors

Auditor

Rayo Pharma Private Limited is audited by DJNV & Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
DJNV & Co.FY 2023115145W

Shareholding

The shareholding of Rayo Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Rayo Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Rayo Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Rayo Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAJCR2164A1ZTGujaratActive08 Apr 2019

To see the full GST registrations and return filing status of Rayo Pharma Private Limited, buy the company report.

Recent activity

Rayo Pharma Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Ashik Dhirubhai Sanghvi was appointed as Director on 23 Oct 2018.

AGM
Rayo Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rayo Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Appointed
Ashik Dhirubhai Sanghvi was appointed as Director.
Appointed
Jigneshkumar Arvindbhai Patel was appointed as Director.
Appointed
Munir Mahendrakumar Shah was appointed as Director.
Incorporation
23 Oct 2018
Rayo Pharma Private Limited was registered on 23 Oct 2018 with Roc Ahmedabad & aged 8 years 20 days as per MCA records.

Frequently asked questions

Rayo Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 October 2018 (8+ years old) and is registered under CIN U33119GJ2018PTC104863.

Rayo Pharma has 3 current directors:

The latest financial statements of Rayo Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Rayo Pharma is 24AAJCR2164A1ZT, registered in Gujarat.

The CIN (Corporate Identification Number) of Rayo Pharma is U33119GJ2018PTC104863. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Rayo Pharma has 1 court case on record: 1 filed by the company. 1 is pending.

Rayo Pharma was incorporated on 23 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Ashik Dhirubhai Sanghvi was appointed as Director on 23 Oct 2018. Jigneshkumar Arvindbhai Patel was appointed as Director on 23 Oct 2018. Munir Mahendrakumar Shah was appointed as Director on 23 Oct 2018.

Yes, Rayo Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0006428).

Rayo Pharma can be reached through the website rayopharma.in. Its registered office is in Ahmedabad, Gujarat, India.